Drug Shortage Report for FLUDARABINE PHOSPHATE FOR INJECTION

Last updated on 2019-11-19 History
Report ID 90935
Drug Identification Number 02283859
Brand name FLUDARABINE PHOSPHATE FOR INJECTION
Common or Proper name FLUDARABINE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) FLUDARABINE PHOSPHATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 2ML
ATC code L01BB
ATC description ANTIMETABOLITES
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2019-09-30
Actual start date
Estimated end date 2019-11-30
Actual end date 2019-11-18
Shortage status Resolved
Updated date 2019-11-19
Company comments Inventory released and available. Inventory to cover 100% market demand for 5 weeks is in-transit to DCs.
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2019-11-19 English Compare
v13 2019-11-18 French Compare
v12 2019-11-18 English Compare
v11 2019-10-01 English Compare
v10 2019-09-19 French Compare
v9 2019-09-19 English Compare
v8 2019-08-29 French Compare
v7 2019-08-29 English Compare
v6 2019-08-22 French Compare
v5 2019-08-22 English Compare
v4 2019-08-07 French Compare
v3 2019-08-07 English Compare
v2 2019-08-06 French Compare
v1 2019-08-06 English Compare

Showing 1 to 14 of 14